Bristol meets with investors to salvage $74 billion Celgene deal

Bristol-Myers Squibb has been meeting with shareholders in Boston and New York over the last two weeks to try to salvage its $74 billion purchase of cancer drugmaker Celgene, the biggest acquisition announced so far this year.

Join us
in New York City on May 21, when we’ll explore some of these topics and more on stage with United Therepeautics CEO Martine Rothblatt, Novartis CEO Vasant Narasimhan, Johnson & Johnson CEO Alex Gorsky and more at our Healthy Returns Conference.

Source link

Leave a Comment

Gastric bypass surgery tied to diabetes remissionWhy Chinese mothers turned away from C-sections